Allergy and Infectious Diseases Research in Indiana
Allergy and Infectious Diseases Research (93.855) awarded $174 million to recipients in Indiana in 167 grants from fiscal 2021 to 2025, 0.8% of the program's national total. Trustees of Indiana University received the most, $81.6 million.
- Awarded in Indiana$174 million
- Awards167
- Share of the program0.8%
- Rank among states24th of 52
- National total$22 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 58 | $24.8 million |
| FY 2022 | 75 | $31.6 million |
| FY 2023 | 85 | $37.8 million |
| FY 2024 | 85 | $39.8 million |
| FY 2025 | 78 | $39.6 million |
Recipients in Indiana
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Trustees of Indiana University | Colleges and universities | 79 | $81.6 million |
| Purdue University | Colleges and universities | 28 | $36.9 million |
| University of Notre Dame Du Lac | Colleges and universities | 33 | $33.8 million |
| Trustees of Indiana University | Colleges and universities | 20 | $14.1 million |
| Miravista Diagnostics LLC | Small businesses | 2 | $3.6 million |
| Medosome Biotec LLC | Small businesses | 1 | $2.0 million |
| Ball State University | Colleges and universities | 1 | $981,939 |
| Marian University Inc | Colleges and universities | 1 | $338,968 |
| Door Pharmaceuticals | Small businesses | 1 | $306,500 |
| Kovina Therapeutics Inc | Small businesses | 1 | $298,527 |
Open opportunities under this program
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- Immune Tolerance Network (UM1 Clinical Trial Required)
- Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)
- NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)
- Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
See all 93 on the program page
Questions people ask
How much Allergy and Infectious Diseases Research money goes to Indiana?
$174 million from fiscal 2021 to 2025, across 167 awards. Indiana ranks 24th of 52 states and territories for this program.
Who receives Allergy and Infectious Diseases Research money in Indiana?
The largest recipient is Trustees of Indiana University, with $81.6 million in 79 awards. Next are Purdue University and University of Notre Dame Du Lac.
Can organizations in Indiana apply now?
Yes, 93 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Allergy and Infectious Diseases Research in other states
Other large programs in Indiana
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Child Care and Development Block Grant
- Special Education Grants to States
- Children's Health Insurance Program
- Title I Grants to Local Educational Agencies
- Temporary Assistance for Needy Families
- Broadband Equity, Access, and Deployment Program